Aβ aggregates, the coaggregate of tau in AD, have been proposed to form after iatrogenic transmission through Aβ seeds secondary to human cadaveric pituitary-derived growth hormone treatments or dural grafting (34–36). The gene discussed is MAPT; the disease is Alzheimer disease.